Immunome Announces Inducement Grants in Accordance with Nasdaq Rule 5635(c)(4)

Immunome Grants Equity Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4) as Part of Talent Expansion Strategy Immunome, Inc. (Nasdaq: IMNM), a clinical-stage biotechnology company pioneering innovative cancer therapies with a focus on first-in-class and best-in-class antibody-based treatments, announced…










